These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 10684717
1. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Molpus KL, Hamblin MR, Rizvi I, Hasan T. Gynecol Oncol; 2000 Mar; 76(3):397-404. PubMed ID: 10684717 [Abstract] [Full Text] [Related]
6. Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. Duska LR, Hamblin MR, Miller JL, Hasan T. J Natl Cancer Inst; 1999 Sep 15; 91(18):1557-63. PubMed ID: 10491432 [Abstract] [Full Text] [Related]
7. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Hamblin MR, Del Governatore M, Rizvi I, Hasan T. Br J Cancer; 2000 Dec 15; 83(11):1544-51. PubMed ID: 11076666 [Abstract] [Full Text] [Related]
8. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M, Hasan T. Br J Cancer; 1994 Sep 15; 70(3):474-80. PubMed ID: 8080733 [Abstract] [Full Text] [Related]
9. Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Goff BA, Blake J, Bamberg MP, Hasan T. Br J Cancer; 1996 Oct 15; 74(8):1194-8. PubMed ID: 8883404 [Abstract] [Full Text] [Related]
10. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy. Shirasu N, Yamada H, Shibaguchi H, Kuroki M, Kuroki M. Int J Cancer; 2014 Dec 01; 135(11):2697-710. PubMed ID: 24740257 [Abstract] [Full Text] [Related]
11. Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Molpus KL, Kato D, Hamblin MR, Lilge L, Bamberg M, Hasan T. Cancer Res; 1996 Mar 01; 56(5):1075-82. PubMed ID: 8640764 [Abstract] [Full Text] [Related]
15. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Harada T, Nakamura Y, Sato K, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H. Oncotarget; 2016 Nov 29; 7(48):79408-79416. PubMed ID: 27765903 [Abstract] [Full Text] [Related]
16. Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting. Liang BJ, Pigula M, Baglo Y, Najafali D, Hasan T, Huang HC. J Nanobiotechnology; 2020 Jan 02; 18(1):1. PubMed ID: 31898555 [Abstract] [Full Text] [Related]
18. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. J Natl Cancer Inst; 2005 Oct 19; 97(20):1516-24. PubMed ID: 16234565 [Abstract] [Full Text] [Related]
19. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H. Mol Cancer Ther; 2015 Jan 19; 14(1):141-50. PubMed ID: 25416790 [Abstract] [Full Text] [Related]